14 completed, 3 terminated, 3 unknown, 2 recruiting. 24 Phase 2, 5 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 24 | Completed 14, Terminated 3, Unknown 3, Recruiting 2, Not yet recruiting 1, Withdrawn 1 |
| Phase 1 | 5 | Completed 4, Terminated 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Airway Obstruction: new trials by email Literature Review of Airway Obstruction trials Research Report on Airway Obstruction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Investigate the Efficacy and Safety of Apomivir® Apomivir®, Placebo - Influenza | Phase 2 | Not yet recruiting | Far East Bio-Tec Co., Ltd | 196 | 2026-05-31 | 2025-05-14 |
| A Study to Learn More About How Well Oxymetazoline HCl 0.05% Nasal Gel Works and How Safe It Is in Healthy Adults Oxymetazoline HCl 0.05% nasal gel, Placebo nasal gel - Nasal Congestion, Nasal Obstruction | Phase 2 | Completed | Bayer | 120 | 2026-04-20 | 2026-06-08 |
| Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants Oxymetazoline + Triamcinolone - Nasal Obstruction, Chronic Rhinitis | Phase 2 | Terminated | Washington University School of Medicine | 3 | 2025-11-10 | 2026-03-23 |
| A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma PF-07275315, Placebo - Asthma | Phase 2 | Recruiting | Pfizer | 252 | 2025-05-20 | 2026-11-06 |
| Nasal Obstruction With Oxymetazoline and Corticosteroids Oxymetazoline Nasal Spray, Budesonide nasal spray - Nasal Obstruction | Phase 2 | Recruiting | Washington University School of Medicine | 80 | 2024-10-15 | 2025-09-11 |
| Biological Effects of Quercetin in COPD Phase II Quercetin 1000 mg, Quercetin 500 MG, Placebo - Chronic Obstructive Pulmonary Disease, Emphysema | Phase 2 | Unknown | Temple University | 30 | 2023-11-01 | 2024-04-08 |
| Chlorpheniramine Maleate Nasal Spray for Chronic Rhinitis CPM, Placebo - Allergic Rhinitis, Nasal Congestion | Phase 2 / Phase 3 | Withdrawn | Larkin Community Hospital | 2019-07-30 | 2023-10-16 | |
| Intranasal Capsaicin Treatment for Non-Allergic Irritant Rhinitis Capsaicin, Placebo - Nonallergic Irritant Rhinitis | Phase 2 | Completed | The University of Texas Health Science Center, Houston | 22 | 2014-10-01 | 2020-08-17 |
| Market Potential of Carbon Dioxide Nasal Spray Carbon Dioxide - Nasal Congestion | Phase 2 | Completed | GlaxoSmithKline | 147 | 2013-11-01 | 2015-04-30 |
| Effectiveness of Continuous Negative External Pressure in Preventing Upper Airway Impairment During Routine Colonoscopy Airway Management System (AMS) - Airway Obstruction, Apnea | Phase 1 / Phase 2 | Completed | 5i Sciences, Inc. | 54 | 2013-03-01 | 2014-08-06 |
| Combination Study Of S-555739/Cetirizine HCl In Adult Patients With Seasonal Allergic Rhinitis S-555739 Dose 1, S-555739 Dose 2, Cetirizine HCl Dose 1 - Seasonal Allergic Rhinitis | Phase 2 | Completed | Shionogi | 779 | 2012-07-01 | 2018-04-27 |
| Effects of AkPharma's Calcium Glycerophosphate Nasal Spray Wash Calcium Glycerophosphate Nasal Spray Wash - Allergic Rhinitis | Phase 1 / Phase 2 | Completed | Drexel University | 17 | 2012-05-01 | 2015-05-25 |
| A Pivotal Study to Assess the Effectiveness of Nasal Dilator (Breathe Right Nasal Strips) Breathe Right Tan (small/medium) nasal strips, Placebo nasal strip - Congestion, Nasal | Phase 2 | Completed | GlaxoSmithKline | 130 | 2010-11-04 | 2018-09-25 |
| A Pivotal Subjective Sleep Study of a Nasal Dilator (Breathe Right Tan) Breathe Right Tan (small/medium) nasal strips, Placebo nasal strip - Congestion, Nasal | Phase 2 | Completed | GlaxoSmithKline | 140 | 2010-10-25 | 2018-09-25 |
| Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU) Bilastine - Allergic Rhinoconjunctivitis, Chronic Urticaria | Phase 1 / Phase 2 | Completed | Faes Farma, S.A. | 36 | 2010-01-01 | 2012-09-26 |
| Study on the Effects of Sitaxsentan on Airway Remodeling in Patients With Severe Asthma sitaxentan, placebo - Effect of Sitaxsentan on Airway Remodeling in Severe Asthma | Phase 2 | Terminated | Institut National de la Santé Et de la Recherche Médicale, France | 17 | 2009-11-01 | 2012-05-10 |
| Exploratory Subjective Sleep Study of a Prototype Nasal Dilator Prototype Nasal Dilator, Marketed Nasal Strip, Placebo Nasal Strip - Sleep Disorders, Congestion, Nasal | Phase 2 | Completed | GlaxoSmithKline | 61 | 2009-10-01 | 2018-04-09 |
| To Characterize the Performance of the Nasal Dilator Strip in Lowering Nasal Resistance During Sleep, Promoting Nasal Route Breathing and Reducing the Signs and Symptoms of Sleep Disordered Breathing in a Group of Chronic Nocturnal Nasal Congestion Sufferers Who Report Trouble With Their Sleep. Prototype nasal dilator strip, No strip - Sleep Disordered Breathing, Congestion, Nasal | Phase 2 | Completed | GlaxoSmithKline | 91 | 2009-09-25 | 2019-07-26 |
| Single-dose Crossover Study to Investigate Pharmacodynamics of AZD3199 AZD3199, Formoterol, Placebo - Asthma, Airway Obstruction | Phase 2 | Completed | AstraZeneca | 37 | 2008-08-01 | 2014-05-19 |
| Study of Polyester Implants for the Treatment of External Nasal Valve Collapse (NVC) Polyester Implants - Nasal Alar Collapse, Bilateral | Phase 1 / Phase 2 | Terminated | Medtronic Xomed, Inc. | 45 | 2008-04-01 | 2012-01-06 |
Showing 20 of 24. Sign in to see all of them.
Nasal Obstruction (16) · Asthma (3) · Rhinitis, Allergic (3) · Sneezing (3) · Dyspnea (2) · Rhinitis (2) · Rhinitis, Allergic, Seasonal (2) · Rhinorrhea (2) · Sleep Apnea Syndromes (2) · Airway Remodeling (1) · Apnea (1) · Chronic Urticaria (1) · Cough (1) · Emphysema (1)
Respiration Disorders (24) · Respiratory Insufficiency (24) · Respiratory Tract Diseases (23) · Otorhinolaryngologic Diseases (17) · Nose Diseases (16) · Pathological Conditions, Signs and Symptoms (12) · Signs and Symptoms (9) · Hypersensitivity, Immediate (7) · Immune System Diseases (7) · Signs and Symptoms, Respiratory (7) · Hypersensitivity (6) · Respiratory Hypersensitivity (6) · Lung Diseases, Obstructive (4) · Bronchial Diseases (3)
Oxymetazoline (3) · Culture Media (2) · Dexamethasone (2) · AZD-3199 (1) · Budesonide (1) · Capsaicin (1) · Carbon Dioxide (1) · Chlorpheniramine (1) · Ethanol (1) · Formoterol Fumarate (1) · Quercetin (1) · Sodium Chloride (1) · Triamcinolone (1) · bilastine (1) · heliox (1)
GlaxoSmithKline (5) · Mackay Memorial Hospital (2) · Washington University School of Medicine (2) · 5i Sciences, Inc. (1) · AstraZeneca (1) · Bayer (1) · Drexel University (1) · Faes Farma, S.A. (1) · Far East Bio-Tec Co., Ltd (1) · Institut National de la Santé Et de la Recherche Médicale, France (1) · Larkin Community Hospital (1) · Medtronic Xomed, Inc. (1) · Pfizer (1) · Shionogi (1) · Temple University (1)
United States (14) · Taiwan (4) · Australia (2) · Germany (2) · Sweden (2) · Argentina (1) · Belgium (1) · Bulgaria (1) · Canada (1) · China (1) · Czechia (1) · Denmark (1) · France (1) · Hungary (1) · Italy (1)
Chao-Hsien Lee, MD (2) · Amber U Luong, MD, PhD (1) · Edward M. Weaver, MD, MPH (1) · Edward S Schulman, MD (1) · Gunilla Hedlin, Prof. Dr. (1) · Hubert Trubel, MD (1) · Lennart Nordvall, Prof. Dr (1) · Liang-Wen Hang, MD (1) · Marcos A Sanchez-Gonzalez (1) · Nathaniel Marchetti (1) · Noel E Cranswick, Prof. Dr. (1) · Nyssa F Farrell, MD (1) · Nyssa Farrell, MD (1)
PMID 31209698, PMID 15725047, PMID 16424722, PMID 16540947, PMID 17605780, PMID 20920189, PMID 22465313, PMID 23907810, PMID 27110692, PMID 27178892, PMID 29800001, PMID 29975735, PMID 30154874, PMID 30850876, PMID 31119695, PMID 32071149, PMID 8874303
2009 (1), R01HL084139 (1), R33AT009991 (1)